Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure

ClinicalTrials.gov ID: NCT00052026

Public ClinicalTrials.gov record NCT00052026. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Placebo-Controlled, 8-Month Study of the Effect of Twice Daily Carvedilol in Children With Congestive Heart Failure Due to Systemic Ventricular Systolic Dysfunction

Study identification

NCT ID
NCT00052026
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shaddy, Robert, M.D.
Individual
Enrollment
161 participants

Conditions and interventions

Interventions

  • carvedilol Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
1 Day to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2000
Primary completion
May 31, 2005
Completion
Jun 30, 2006
Last update posted
Dec 24, 2008

2000 – 2006

United States locations

U.S. sites
21
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35249-6852
Mattel Children's Hospital at UCLA Los Angeles California 90025
Children's Hospital Los Angeles Los Angeles California 90027
Stanford University Palo Alto California 94303
University of Colorado Denver Colorado 80218
University of Miami Miami Florida 33101
University of Southern Florida St. Petersburg Florida 33701
Children's Memorial Hospital Chicago Illinois 60614
Children's Hospital, Boston Boston Massachusetts 02115
C.S. Mott Children's Hospital Ann Arbor Michigan 48109
Children's Hospital of Michigan Detroit Michigan 48201-2196
Washington University St Louis Missouri 63110-1014
NYU Medical Center New York New York 10016
Columbia University New York New York 10032-1537
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213
Vanderbilt Children's Hospital Nashville Tennessee 37332
UT Southwestern Medical Center Dallas Texas 75235-7794
Texas Children's Hospital Houston Texas 77030
University of Utah Salt Lake City Utah 84132
Seattle Childrens Hospital and Regional Medical Center Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00052026, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 24, 2008 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00052026 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →